Health - Google News: Sanofi draws fire over cost of MS drug Lemtrada - Reuters

Health - Google News Google News

Sanofi draws fire over cost of MS drug Lemtrada - Reuters Nov 1st 2012, 01:01 Sanofi draws fire over cost of MS drug Lemtrada Reuters Journal says MS drug could be too costly once approved. * Criticizes withdrawal of leukaemia drug Campath. PARIS Nov 1 (Reuters) - Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for ... and more »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: